PositiveID

Biological Detection and Diagnostics

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.

Click here to view our products

Recent News

October 10, 2014
PositiveID Corporation and ENSCO Awarded Contract for U.S. Department of Homeland Security SenseNet Program
more
September 23, 2014
PositiveID Accelerates Prototype Development of Its Firefly Dx System for Real-Time Molecular Diagnostic Testing
more
September 9, 2014
PositiveID's M-BAND Systems Shipped to Aberdeen Proving Ground for Continued Testing to Protect U.S. Military
more
September 2, 2014
PositiveID Corporation to Present at the Rodman & Renshaw Global Investment Conference
more
August 22, 2014
PositiveID's Handheld Bio-Threat Testing Device Featured in Computerworld
more
View Archives

PositiveID Corporation™ (OTCQB: PSID)

PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.



Click here to watch the video



Click here to watch the video

M-BAND

PositiveID specializes in airborne pathogen detection, rapid clinical diagnostics and sample preparation applications. more

Company report

PositiveID and Secure Strategy Group have published a report on PositiveID. more

Firefly

PositiveID is developing a portable, handheld biological detection system. more

PositiveID™ Corporation, 2014 - All Rights Reserved